UBS Group AG Purchases 7,256 Shares of Masimo Co. (NASDAQ:MASI)

UBS Group AG boosted its position in shares of Masimo Co. (NASDAQ:MASI – Get Rating) by 8.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 96,655 shares of the medical equipment provider’s stock after buying an additional 7,256 shares during the quarter. UBS Group AG’s holdings in Masimo were worth $14,300,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. California Public Employees Retirement System raised its holdings in Masimo by 21.1% during the 3rd quarter. California Public Employees Retirement System now owns 113,349 shares of the medical equipment provider’s stock valued at $16,000,000 after buying an additional 19,786 shares during the last quarter. Pathstone Family Office LLC increased its position in Masimo by 91.1% during the 3rd quarter. Pathstone Family Office LLC now owns 6,841 shares of the medical equipment provider’s stock valued at $966,000 after purchasing an additional 3,262 shares during the period. Hsbc Holdings PLC increased its position in Masimo by 399.1% during the 3rd quarter. Hsbc Holdings PLC now owns 263,738 shares of the medical equipment provider’s stock valued at $37,967,000 after purchasing an additional 210,896 shares during the period. Healthcare of Ontario Pension Plan Trust Fund increased its position in Masimo by 81.2% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 145,500 shares of the medical equipment provider’s stock valued at $20,539,000 after purchasing an additional 65,223 shares during the period. Finally, Wesleyan Assurance Society increased its position in Masimo by 62.5% during the 4th quarter. Wesleyan Assurance Society now owns 1,300 shares of the medical equipment provider’s stock valued at $192,000 after purchasing an additional 500 shares during the period. 87.67% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on MASI. StockNews.com began coverage on shares of Masimo in a research report on Thursday. They set a “hold” rating on the stock. Piper Sandler boosted their price objective on shares of Masimo from $135.00 to $150.00 and gave the company a “neutral” rating in a research report on Wednesday, March 1st. Stifel Nicolaus boosted their price objective on shares of Masimo from $200.00 to $205.00 in a research report on Wednesday, May 10th. Raymond James boosted their price objective on shares of Masimo from $187.00 to $198.00 and gave the company an “outperform” rating in a research report on Wednesday, March 1st. Finally, Needham & Company LLC boosted their price objective on shares of Masimo from $192.00 to $207.00 in a research report on Wednesday, May 10th. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $188.88.

Masimo Stock Up 0.1 %

NASDAQ:MASI opened at $163.46 on Friday. The firm’s 50-day moving average price is $181.93 and its 200-day moving average price is $163.34. The company has a market capitalization of $8.63 billion, a PE ratio of 74.98 and a beta of 0.87. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.16 and a quick ratio of 1.30. Masimo Co. has a 1-year low of $108.89 and a 1-year high of $198.00.

Masimo (NASDAQ:MASI – Get Rating) last announced its quarterly earnings data on Tuesday, May 9th. The medical equipment provider reported $0.87 EPS for the quarter, beating the consensus estimate of $0.83 by $0.04. Masimo had a net margin of 5.16% and a return on equity of 19.32%. The company had revenue of $565.00 million for the quarter, compared to the consensus estimate of $557.87 million. During the same period in the prior year, the firm posted $0.93 EPS. Masimo’s revenue for the quarter was up 85.7% on a year-over-year basis. On average, equities analysts predict that Masimo Co. will post 4.76 EPS for the current fiscal year.

About Masimo

(Get Rating)

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge.